Pharm Analys Res J

Submissions

Online Submissions

Already have a Username/Password for Pharmaceutical Analysis and Research Journal?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

Manuscript Text Components 

Title Page

The title must reflect the purposes and findings of the work in a manner that assists in classification and indexing. Abbreviations and trade names should not be included in the titles. Succinct titles are encouraged. Titles should be followed by the names of the authors and by the addresses of all contributing laboratories. The name of the author to whom inquiries should be directed should be marked with an asterisk (*). The institution address together with the e-mail address of the corresponding author should be given, using an asterisk.

Abstract

Abstracts should accompany all manuscripts and should explain concisely the objective, methods, and most important results and conclusions in the report. Any references should be cited in full, and footnotes and abbreviations should be avoided to prevent ambiguity in cases where only the abstract is published (e.g., Chemical Abstracts). Initial acceptance of manuscripts for consideration will be based primarily on review of the abstract. Abbreviations should be defined in the abstract and again in the manuscript body.

Keywords

Authors must have 5-6 significant keywords (separated by semicolon) that aid the reader in literature retrieval included after the abstract.

Abbreviations

Standard abbreviations should be used throughout the manuscript.

Introduction

The purpose of the study and its relation to and extension of previous work in the field should be included. Detailed or lengthy descriptions of routine experimental or theoretical procedures should be avoided. Extensive literature reviews should also be excluded. The Introduction should state the rationale and hypothesis/objectives of the study. Authors must ensure that adequate citation are given to relevant work, making sure that prior contributions are acknowledged.

Experimental Section

Experimental descriptions should be as concise as possible. This section should provide a clear, unambiguous description of materials, methods, and equipment in sufficient detail to permit independent repetition of the work. Novel experimental procedures should be described in detail, while published procedures should be cited by reference number only. General reaction conditions should be given only once. Authors must emphasize any unexpected, new, and/or significant hazards or risks associated with the reported work. This information should be in the experimental details section of the full article or communication. The journal will not publish work using unknown compounds (e.g., compound X). For animal and human studies, appropriate committee permissions must be listed, including the study number.

Results

Text, tables, and figures can be used to describe the results as necessary. However, data should appear in only one format. Only the most significant and representative data should be included in the body of the manuscript. Extended or supplemental results that support the main findings of the paper should appear as Supporting Information, which is published on the Web.

Discussion

Authors should use this section for their interpretation of the results and examination of their relation to and extension of the existing body of literature. Information given elsewhere, e.g., in the Results or Introduction, should not be repeated. Highly speculative suggestions should also be excluded.

Conclusions

This section is a single paragraph that summarizes the importance of findings to the field and future directions of the work. This section should be clearly different from the abstract.

Acknowledgments

Mention of technical assistance, advice from colleagues, gifts, etc. should be made. Financial support should also be described in detail in this section. Funding should be reported as: “Funding: This work was supported, in part, by Grant Name (No. 123456).

References

Literature references and notes must be numbered in one consecutive series by order of mention in the text, and article titles should be included in the reference list. They should be cited in the text with superscript numbers. The accuracy of the references is the responsibility of the author. Because, in the Web edition, references are linked to various electronic sources, the accuracy of the references is critical. Reference formats are as follows.

Reference to a journal publication

[1]     Fawwaz M, Baits M, Saleh A, Irsyaq MR, Pratiwi RE. Isolation of glucosamine HCl from Penaeus monodon. Int Food Res J. 2018; 25(5): 2176-2180.

[2]     Huskisson EC. Glucosamine and chondroitin for osteoarthritis. J Int Med Res. 2008; 36(6): 1-19.

[3]     Pesek J, Matyska M, Jimena A, Juan J, Jo A, Berioso B. Analysis of glucosamine using aquos normal phase chromatography. LWT – Food Sci Technol.2016; 65(1): 777-782. 

[4]     Taşkin P, Casinağ H, Şen M. The effect of degree of deacetylation on the radiation induced degradation of chitosan. Radiat Phys Chem. 2014; 94(1): 236-239. 

[5]     Shahidi F and Abuzaytoun RB. Chitin, Chitosan, and Co-Products: Chemistry, Production, Applications, and Health Effects. Academic Press. 2005; 49: 93–135. 

 [4]    Booker A, Agapouda A, Frommenwiler DA, Scotti F, Reich E, Heinrich M. St John's wort (Hypericum perforatum) products - an assessment of their authenticity and quality. Phytomedicine. 2018; 40[---1] : 158-164.

Reference to a book:

[6]     Silverman RB, The Organic Chemistry of Drug Design and Drug Action, fourth ed., Elsever, Burlington, MA, USA 2000.

Reference to a chapter in an edited book:

[7]     Şener G, Sakarcan A, Yeğen B. Melatonin as a radioprotective agent. In: Montilla P, Túnez I. (Eds). Melatonin: Present and Future. Nova Science Publishers, Inc., New York, 2008, pp.127-142.

Theses:

[8]     Tatar E. PhD Thesis. Synthesis and characterization of novel 1,3-thiazolidine-4-ones derived from 2-(aroylamino)-3-methyl butyric acid hydrazide. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Haydarpaşa, İstanbul, Turkey, 2009.

Reference to a website:

[9]     VCCLAB, Virtual Computational Chemistry Laboratory. http://www.vcclab.org  (accessed March 18, 2017).

[10]   PASS (Prediction of Activity Spectra for Substances) program. http://www.way2drug.com/passonline (accessed July 18, 2015).

[11]   WHO Global tuberculosis report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1, (accessed July 18, 2015).

 

Submitted manuscripts should be listed as “in press” only if formally accepted for publication. Results that have not been peer-reviewed or published should be avoided where possible. Published work for which pagination is unavailable may be cited by the Digital Object Identifier (DOI). Authors must receive written permission to use unpublished work of others or to use material taken directly from a copyrighted publication. Any footnotes to the text should be incorporated in the correct numerical sequence with the references.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
 

Copyright Notice

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
  • The author must submit Copyright form After acceptance of the article.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.